Evaluation of responsive gene expression as a sensitive and specific biomarker in patients with ulcerative colitis. [electronic resource]
Producer: 20130820Description: 221-9 p. digitalISSN:- 1536-4844
- Adult
- Aminosalicylic Acids -- therapeutic use
- Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
- Antigens, Differentiation -- genetics
- Azo Compounds -- therapeutic use
- CD18 Antigens -- genetics
- Case-Control Studies
- Cohort Studies
- Colitis, Ulcerative -- drug therapy
- Double-Blind Method
- Female
- Gene Expression Profiling
- Genetic Markers
- Humans
- Interleukin-2 Receptor alpha Subunit -- genetics
- Logistic Models
- Male
- Mesalamine -- therapeutic use
- Middle Aged
- Polymerase Chain Reaction
- Receptors, Interleukin-1 Type II -- genetics
- Sensitivity and Specificity
- Severity of Illness Index
- Transcriptome
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.